Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparin-induced thrombocytopenia

A K Gupta1, M J Kovacs, D N Sauder

  • 1Department of Medicine, University of Toronto, Sunnybrook Health Science Center, North York, Ontario, Canada.

The Annals of Pharmacotherapy
|February 26, 1998
PubMed
Summary

Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy. Early recognition and prompt management of HIT are crucial to prevent severe outcomes like limb amputation or death.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral edema due to nifedipine-itraconazole interaction: a case report.

Archives of dermatology·1996
Same author

High frequency 40-MHz ultrasound. A possible noninvasive method for the assessment of the boundary of basal cell carcinomas.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·1996
Same author

Effect of ionizing radiation on AP-1 binding activity and basic fibroblast growth factor gene expression in drug-sensitive human breast carcinoma MCF-7 and multidrug-resistant MCF-7/ADR cells.

The Journal of biological chemistry·1995
Same author

Role of cellular casein kinase II in the function of the phosphoprotein (P) subunit of RNA polymerase of vesicular stomatitis virus.

The Journal of biological chemistry·1995
Same author

Fundus imaging in patients with cataract: role for a variable wavelength scanning laser ophthalmoscope.

The British journal of ophthalmology·1995
Same author

Age and gender differences in the impact of psoriasis on quality of life.

International journal of dermatology·1995

Area of Science:

  • Hematology
  • Pharmacology
  • Clinical Medicine

Background:

  • Heparin therapy is widely used but carries the risk of heparin-induced thrombocytopenia (HIT).
  • HIT is an immune-mediated complication with two distinct types: Type 1 and Type 2.
  • Type 2 HIT is more severe and poses significant clinical risks.

Observation:

  • This report focuses on Type 2 HIT, detailing five patient cases.
  • Patients developed Type 2 HIT during heparin therapy, with some experiencing severe complications.
  • Complications included limb amputation and fatalities.

Findings:

  • Thrombocytopenia in patients on heparin therapy should raise suspicion for HIT.
  • HIT typically manifests 5-8 days after initiating heparin, with platelet counts dropping below 100 x 10(3)/mm3.
  • Platelet counts usually normalize within 5-7 days after heparin discontinuation, but thrombosis can still occur.

Implications:

  • Awareness of HIT is vital for healthcare providers managing patients on heparin.
  • Prompt diagnosis and appropriate management of HIT can prevent serious adverse events.
  • Management strategies vary based on HIT severity, ranging from asymptomatic thrombocytopenia to severe cases with thrombosis.

Related Experiment Videos